Department of Chemistry, Stanford University, Stanford, California 94305, USA.
J Pharm Sci. 2010 Oct;99(10):4261-6. doi: 10.1002/jps.22147.
A key challenge in developing RNAi-based therapeutics is efficient delivery of functional short interfering RNA (siRNA) to target cells. To address this need, we have used a supercritical CO(2) process to incorporate siRNA in biodegradable polymer nanoparticles (NPs) for in vivo sustained release. By this means we have obtained complete encapsulation of the siRNA with minimal initial burst effect from the surface of the NPs. The slow release of a fluorescently labeled siRNA mimic (siGLO Red) was observed for up to 80 days in vivo after intradermal injection into mouse footpads. In vivo gene silencing experiments were also performed, showing reduction of GFP signal in the epidermis of a reporter transgenic mouse model, which demonstrates that the siRNA retained activity following release from the polymer NPs.
开发基于 RNAi 的治疗方法的一个关键挑战是将功能性短干扰 RNA(siRNA)有效递送到靶细胞。为了解决这一需求,我们使用超临界 CO2 工艺将 siRNA 包封在可生物降解的聚合物纳米颗粒(NPs)中,以实现体内的持续释放。通过这种方法,我们获得了 siRNA 的完全包封,并且从 NPs 表面观察到最小的初始突释效应。在通过皮内注射到小鼠足底后,体内观察到荧光标记的 siRNA 模拟物(siGLO Red)长达 80 天的缓慢释放。还进行了体内基因沉默实验,结果显示报告转基因小鼠模型的表皮中的 GFP 信号减少,这表明 siRNA 在从聚合物 NPs 释放后仍保持活性。